Center For Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Center For Asset Management's VRTX Position: Q2 2026 in Review
Center For Asset Management opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 405 shares worth $201K. The stake represents 0.09% of the portfolio and ranks #150 among its holdings. This is a return to the name: Center For Asset Management previously reported a position in VRTX as recently as Q4 2025.
Center For Asset Management first reported a position in VRTX in Q1 2023 and has held it in 8 quarters since. The position peaked at $1.06M in Q2 2023. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Center For Asset Management held 405 shares of Vertex Pharmaceuticals worth $201K as of Q2 2026.
- Vertex Pharmaceuticals was a new Center For Asset Management position in Q2 2026.
- Vertex Pharmaceuticals made up 0.09% of Center For Asset Management's portfolio in Q2 2026, its #150 holding.
- Center For Asset Management first reported a position in Vertex Pharmaceuticals in Q1 2023 and has held it in 8 quarters since.
- Center For Asset Management's Vertex Pharmaceuticals position peaked at $1.06M in Q2 2023.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Center For Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.